A detailed history of Ethos Financial Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ethos Financial Group, LLC holds 1,093 shares of CRL stock, worth $260,046. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,093
Previous 1,386 21.14%
Holding current value
$260,046
Previous $328,000 9.76%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$203.52 - $273.43 $59,631 - $80,114
-293 Reduced 21.14%
1,093 $296,000
Q4 2023

Feb 07, 2024

BUY
$164.52 - $238.84 $228,024 - $331,032
1,386 New
1,386 $328,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $12.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ethos Financial Group, LLC Portfolio

Follow Ethos Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethos Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ethos Financial Group, LLC with notifications on news.